Friday, October 14, 2022

United Fakes True Alien Invasion Countdown

FleurBrun in Colombia

Thursday, October 13, 2022

VATICAN EXPOSED

- Your birth, death and serial number. All on record at the Vatican who say they "own" you

Once the STRAWMAN is created, it is considered a Corporation, as corporations cannot do business w/ living beings. All government entities are corporations. “Corporation” when broken down means “Corpse Oration” or dead talk. This is the dead society that runs the program/matrix.
— STRAWMAN (@BradandCircus) October 12, 2022

pic.twitter.com/cD5vToZh4Q
— barbara engelhart (@barbaraengelh18) October 13, 2022

When the Phoenicians settled on land, they first settled in Venice, and called themselves Venicians, then to Rome where they created their own sovereign country within the country of Italy. They own the largest collection of ancient books and manuscripts on the planet.
— STRAWMAN (@BradandCircus) October 12, 2022

When you are summoned to go to court by the black robes priests, I mean judges, it is the STRAWMAN they are summoning because only dead spirits can be summoned. You act on behalf of this entity every time you pay a ticket, a fine, pay taxes, go to jail etc.
— STRAWMAN (@BradandCircus) October 12, 2022

Wednesday, October 12, 2022

Press Release Pfizer: behind the science of vaccines.

Pfizer. pic.twitter.com/gtddo6WzAr
— D. Scott @eclipsethis2003 (@eclipsethis2003) October 15, 2022

Press Release Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19 https://www.pfizer.com/news/press-release/press-release-detail/pfizer-provide-us-government-10-million-treatment-courses Antiviral Candidate to Help Combat COVID-19 Thursday, November 18, 2021 - courses of its investigational COVID-19 oral antiviral candidate, …https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-additional-phase-23-study-results Press Release Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Deathhttps://www.pfizer.com/news/press-release/press-release-detail/ema-issues-advice-potential-early-use-pfizers-novel-covid Pfizer Press release COVID-19 Medicines Research Pfizer Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment …https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-us-fda-emergency-use-authorization-novel Press Release EMA Issues Advice for Potential Early Use of Pfizer’s Novel COVID-19 Oral Antiviral Candidate Potential Early Use of Pfizer’s Novel COVID-19 Oral Antiviral Candidate be used for treatment of adults with COVID-19 who do not require …https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-us-fda-emergency-use-authorization-novel Press Release Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate an 89% reduction in risk of COVID-19-related hospitalization or …https://www.pfizer.com/news/press-release/press-release-detail/pfizer-seeks-emergency-use-authorization-novel-covid-19 Press Release Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants Pfizer Press release COVID-19 Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric … Press Release Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults Pfizer Press release COVID-19 Research Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for …https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-23-study-novel-covid-19-oral Press Release Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment Pfizer Press release COVID-19 Medicines Pfizer Receives Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment … Press Release Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment Pfizer Press release COVID-19 Medicines Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment Thursday, … Press Release Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA nominally significant 62% decrease in COVID-19-related medical visits per at least one risk factor for severe COVID-19 Pfizer to cease enrollment … Press Release Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study Press release Research Pfizer’s Novel COVID-19 Oral Antiviral Treatment high-risk adults with COVID-19 In the overall study … Tidbits by Scotty: behind the science of vaccines.: @GentryTrotter You do know about the 2 pfizer locations in StLouis? how much $$$ has @pfizer been giving to Missouri politicians the past ...

behind the science of vaccines.

@GentryTrotter You do know about the 2 pfizer locations in StLouis? how much $$$ has @pfizer been giving to Missouri politicians the past few years? https://t.co/vUoDgmBfh7
— systembuster (@stlsystembuster) October 13, 2022

@pfizer StLouis has 613 articles on Covid. https://t.co/u6cOJVyjng pic.twitter.com/doLPdav5SC
— systembuster (@stlsystembuster) October 13, 2022

For everyone who didn't know #StLouis, Missouri has 2 Pfizer locations https://t.co/u6cOJVPmpg

Why isn't this news on the Local StLouis FakeNews TV Stations? or the @PostDispatchbiz pic.twitter.com/Vy2jUS5CGq
— systembuster (@stlsystembuster) October 13, 2022

https://www.pfizer.com/stories/podcasts/antigen

The Antigen podcast goes behind the science of vaccines. We examine basic science principles, review vaccine history, explore the many facets of their global impact (including COVID-19), and the public sentiment about vaccines around the world.

Season 1 is an eight-part audio-documentary style podcast about the scientific, cultural, and political elements of vaccination. Hear from leading experts about the past, present, and future of this important innovation, as well as people whose families have been impacted by vaccine-preventable diseases.

Season 2 focuses on COVID-19, connecting with experts to give accurate information and updates on the global response to the pandemic. Over the course of the four-part mini-series, we look back at past global health emergencies, discuss efforts across the industry to research potential coronavirus vaccines and treatments, and look ahead to life after a crisis.

Season 3 is coming this Fall 2022!

What's Next? Coronavirus, Disease X, Maternal & Adult Immunization

S2:B

Science Will Win: a crash course in gene therapy